Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
ActiTest
Description:
A noninvasive liver assessment test that uses blood biomarkers to estimate hepatic necroinflammatory activity in chronic liver disease.
Primary topic:
Liver Disease Diagnosis and Treatment (73%)
Related topics:
Liver Disease Diagnosis and Treatment (73%),
Hepatitis C virus research (12%)
OpenAlex ID:
keywords/actitest
Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C
2004
·
Thierry Poynard
, Françoise Imbert-Bismut
, et al.
·
Comparative Hepatology
·
380
PDF
Prospective Analysis of Discordant Results between Biochemical Markers and Biopsy in Patients with Chronic Hepatitis C
2004
·
Thierry Poynard
, Mona Munteanu
, et al.
·
Clinical Chemistry
·
357
Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B
2003
·
Robert P. Myers
, Marie-Hélène Tainturier
, et al.
·
Journal of Hepatology
·
348
Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data
2012
·
Thierry Poynard
, Guillaume Lassailly
, et al.
·
PLoS ONE
·
161
PDF
Independent Prospective Multicenter Validation of Biochemical Markers (Fibrotest-Actitest) for the Prediction of Liver Fibrosis and Activity in Patients with Chronic Hepatitis C: The Fibropaca Study
2006
·
Philippe Halfon
, Marc Bourliere
, et al.
·
The American Journal of Gastroenterology
·
160
FibroTest-ActiTest as a non-invasive marker of liver fibrosis
2008
·
Philippe Halfon
, Mona Munteanu
, et al.
·
Gastroentérologie Clinique et Biologique
·
142
Systematic review: non‐invasive methods of fibrosis analysis in chronic hepatitis C
2009
·
J. O. SMITH
, R. K. STERLING
·
Alimentary Pharmacology & Therapeutics
·
141
PDF
Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors
2004
·
Françoise Imbert-Bismut
, Djamila Messous
, et al.
·
Clinical Chemistry and Laboratory Medicine (CCLM)
·
139
A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease
2002
·
Philippe Halfon
, Françoise Imbert-Bismut
, et al.
·
Comparative Hepatology
·
123
PDF
Hepatitis C in 6,865 Patients 65 yr or Older: A Severe and Neglected Curable Disease?
2006
·
Dominique Thabut
, Sophie Le Calvez
, et al.
·
The American Journal of Gastroenterology
·
120
Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity
2011
·
Guillaume Lassailly
, Robert Caiazzo
, et al.
·
European Journal of Gastroenterology & Hepatology
·
118
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference
2016
·
M. Munteanu
, D. Tiniakos
, et al.
·
Alimentary Pharmacology & Therapeutics
·
112
Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus
2019
·
Fernando Bril
, Michael J McPhaul
, et al.
·
Journal of Investigative Medicine
·
97
An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load
2008
·
Yen Ngo
, Yves Benhamou
, et al.
·
PLoS ONE
·
80
PDF
FibroMAX™: towards a new universal biomarker of liver disease?
2007
·
Rachel Morra
, Mona Munteanu
, et al.
·
Expert Review of Molecular Diagnostics
·
76
Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors
2004
·
Francoise Imbert-Bismut
, Djamila Messous
, et al.
·
Clinical Chemistry and Laboratory Medicine (CCLM)
·
71
Biopsy or Biomarkers: Is There a Gold Standard for Diagnosis of Liver Fibrosis?
2004
·
Nezam H Afdhal
·
Clinical Chemistry
·
63
The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease
2006
·
Dominique Thabut
, Sylvie Naveau
, et al.
·
Journal of Hepatology
·
60
Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®)
2014
·
Thierry Poynard
, Julien Vergniol
, et al.
·
Journal of Hepatology
·
53
Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy
2010
·
Jiannis Anastasiou
, Akeel Alisa
, et al.
·
European Journal of Gastroenterology & Hepatology
·
43
Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest–ActiTest) in patients infected by hepatitis B virus
2009
·
T. Poynard
, Y. Ngo
, et al.
·
Journal of Viral Hepatitis
·
43
Biomarkers as a first-line estimate of injury in chronic liver diseases: Time for a moratorium on liver biopsy?
2005
·
Thierry Poynard
, Vlad Ratziu
, et al.
·
Gastroenterology
·
43
PDF
Noninvasive Markers of Fibrosis for Longitudinal Assessment of Fibrosis in Chronic Liver Disease: Are They Ready for Prime Time?
2006
·
Paul J Thuluvath
, Karen L Krok
·
The American Journal of Gastroenterology
·
39
Intra-individual fasting versuspostprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest)
2004
·
Mona Munteanu
, Djamila Messous
, et al.
·
Comparative Hepatology
·
38
PDF
ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure
2010
·
T. Poynard
, M. Munteanu
, et al.
·
Gastroentérologie Clinique et Biologique
·
36
Show more works
View as search
Works count:
110
Citation count:
3,564
Year
Topic
Type